MoneyWorks4Me

Strides Pharma Science informs about press release

22 Dec 2022 Evaluate
Strides Pharma Science has informed that it enclosed press release ‘Receipt of AUD 94 million on account of deferred consideration on the sale of the Company’s Australian operations in 2019’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..